Status:

COMPLETED

Effect of EIT-guided PEEP Titration on the Prognosis of Patients with Moderate to Severe ARDS

Lead Sponsor:

Southeast University, China

Conditions:

Clinical Outcomes

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Acute respiratory syndrome distress (ARDS) is a clinical common syndrome with high mortality. Mechanical ventilation (MV) is the cornerstone of management of ARDS but can lead to ventilator-induced lu...

Detailed Description

This is a prospective, multicenter, single-blind, parallel-group, adaptive randomized controlled trial (RCT) with intention-to-treat analysis which aims to determine the effects of PEEP setting guided...

Eligibility Criteria

Inclusion

  • Age≥18 years
  • Moderate-to-severe ARDS, defined by the ARDS Definition Task Force in the Berlin definition (partial pressure of arterial oxygen \[PaO2\]:FiO2 ratio ≤200 mmHg with a PEEP ≥5 cmH2O)
  • Diagnosis of ARDS less than 72 hours

Exclusion

  • Expected to be mechanically ventilated for less than 48 hours
  • Severe chronic respiratory diseases requiring long-term home oxygen therapy or noninvasive MV
  • Undrained pneumothorax or subcutaneous emphysema
  • Undergoing extracorporeal membrane oxygenation (ECMO) before enrollment
  • Contraindication to the use of EIT (pacemaker, automatic implantable cardioverter defibrillator, and implantable pumps)
  • Severe neuromuscular disease
  • Hemodynamic instability
  • Contraindications to hypercapnia, such as intracranial hypertension or acute coronary syndrome
  • Severe other organs dysfunction with a low expected survival (7 days) or palliative care
  • Solid organ or hematologic tumors with the expected survival time less than 30 days
  • Participating in other clinical trials within 30 days
  • Pregnancy
  • Refusal to sign the informed consent

Key Trial Info

Start Date :

February 20 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 20 2023

Estimated Enrollment :

190 Patients enrolled

Trial Details

Trial ID

NCT05207202

Start Date

February 20 2022

End Date

July 20 2023

Last Update

March 20 2025

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

the First Affiliated Hospital of Guangzhou Medical University, Department of Critical Care Medicine

Guangzhou, Guangdong, China, sonysang999@aliyun.com

2

Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University

Nanjing, Jiangsu, China, 210000

3

Department of Critical Care Medicine, Renji Hospital

Shanghai, Shanghai Municipality, China, 200120

4

Department of Critical Care Medicine, Zhongshan Hospital of Fudan University

Shangha, Shangha, China, 200032